Purilogics develops industry-leading membrane technologies for the biopharmaceutical industry. Our proprietary products are designed for use in research and early-stage development laboratories, to support market entry where rapid drug purification is essential to discovery. Our goal is to help sector specialists get biologics to market faster, where they are needed to support the large and growing population of patients with long-term, chronic conditions such as cancers, cardiovascular diseases, and autoimmune disorders. Talk to us about mRNA/OdT plus MCP and NAEX at the show.